Showing results (1191-1200 of 1,538) with videos related to

Sort By:
Pageof 154
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2017
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 StudyHans J Hammers, Elizabeth R Plimack, Jeffrey R Infante, et al.
Clinical Genitourinary Cancer|November 16, 2021
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial CarcinomaYung Lyou, Jonathan E Rosenberg, Jean Hoffman-Censits, et al.
The Oncologist|July 11, 2023
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell CarcinomaAlexander Chehrazi-Raffle, Sally Leong, Sana Ali, et al.
The Lancet. Neurology|June 9, 2019
Parkinson's disease in the Western Pacific RegionShen-Yang Lim, Ai Huey Tan, Azlina Ahmad-Annuar, et al.
European Urology Focus|July 21, 2017
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy ResponseThai H Ho, Toni K Choueiri, Kai Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma CohortsSumanta K Pal, Yohann Loriot, Andrea Necchi, et al.
European Urology|August 28, 2020
Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial CarcinomaYung Lyou, Petros Grivas, Jonathan E Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell CarcinomaZeynep B Zengin, Caroline Weipert, Nicholas J Salgia, et al.
Plos One|May 25, 2012
Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosisXiwei Wu, Lihong Weng, Xuejun Li, et al.
JCO Global Oncology|March 26, 2026
Exercise Counseling and Referral Practices Among Oncology Care Physicians in Latin America: A Multinational Survey StudyPaulo Gustavo Bergerot, Cristiane Decat Bergerot, Errol J Philip, et al.
Pageof 154